Paper Details

  1. Home
  2. Paper Details

[Evaluation on ceftriaxone administered intravenously in neonates].

Author: ChikaokaH, KamigakiM, MatsumotoK, NakanishiY, NakazawaS, NaritaA, NiinoK, SatohH, SuzukiH

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
English AbstractA summary of a research paper/publication written in English for a wider audience.

Overview

Ceftriaxone (CTRX) was effective in treating infections in neonates, including sepsis, pneumonia, and meconium aspiration syndrome. No significant side effects were observed.
Paper Details　
Original Abstract of the Article :
Ceftriaxone (CTRX) was clinically evaluated and its pharmacokinetics studied in neonates. The results obtained are summarized below. 1. Blood levels of CTRX at 8 to 12 hours after intravenous injection with a single dose of 10 to 20 mg/kg ranged from 14.9 to 32.8 micrograms/ml, while T1/2 ranged fro...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/3404643

データ提供：米国国立医学図書館（NLM）

Ceftriaxone: A Powerful Weapon Against Infections in Neonates

This study evaluates the use of [ceftriaxone (CTRX)] in [neonates]. CTRX is a widely used antibiotic, and this study examines its [pharmacokinetics and efficacy] in this vulnerable population. The researchers found that CTRX was effective in treating [infections] in neonates, with good safety and tolerability. This research provides valuable information for clinicians who treat neonates with infections.

Navigating the Desert of Neonatal Infections

Treating neonates with infections is a delicate balance. This study provides a guide for clinicians, offering insights into the effective use of CTRX. It's like having a map through the complex terrain of neonatal infections, helping doctors navigate the challenges and make informed decisions.

Protecting the Most Vulnerable

The study's findings highlight the importance of careful drug selection and monitoring in neonates. It emphasizes the need for [evidence-based practices] to ensure the safety and effectiveness of treatment. This is a vital reminder that we must prioritize the well-being of the most vulnerable members of our society.

Dr. Camel's Conclusion

This research provides valuable information on the use of ceftriaxone in neonates. It reinforces the importance of careful drug selection and monitoring in this vulnerable population, promoting safe and effective treatment practices.
Date :
  1. Date Completed 1988-09-15
  2. Date Revised 2016-11-16
Further Info :

Pubmed ID

3404643

DOI: Digital Object Identifier

3404643

Related Literature

Article Analysis
・Side Effects of cefotaxime injection
SNS
PICO Info
in preparation
Languages

Japanese

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.